iCAD, Inc. (Nashua, NH, USA), a provider of image analysis and workflow solutions for the early detection of cancer, announced the launch of the product suite, which is a comprehensive quantitative image analysis solution, brings together the company's current products SpectraLook and VividLook with the new OmniLook and VersaVue Enterprise, to offer a comprehensive quantitative image analysis suite for cancer detection, staging, localization, treatment planning, and serial monitoring.

"The new advanced MRI product suite will improve workflow efficiencies to aid in expedient clinical decision making and treatment for patients, with an ultimate goal of delivering improved patient care.”

Advanced workflow and analysis tools simplify and streamline case review. The MRI Product suite features include: integrated three-dimensional (3D)/4D displays for rapid, efficient interpretation; colorized displays on any underlying MR sequence; fast and efficient creation of customized hanging protocols; instant creation of 2D, 3D, maximum intensity projection (MIP), and multiplanar reformat (MPR) images from any image in the viewport on the fly; and sophisticated image manipulation icons in each viewport.

VersaVue Enterprise employs thin client architecture to deliver real-time data access and eliminates the need to purchase redundant hardware. The software features on-demand viewing of studies anytime, anywhere to speed workflow as well as shared knowledge of study status from a single, shared database.

OmniLook, a complementary software module to iCAD's existing breast MR (SpectraLook) and prostate MR (VividLook) solutions, applies image analysis using a pharmacokinetic model for other organs of interest, such as liver, kidney, and brain where dynamic contrast imaging may provide further clinical insight. OmniLook gives clinicians the full flexibility to meet the clinical needs of a growing practice.

"iCAD is 100% focused on developing and providing the most sophisticated image analysis solutions to help clinicians increase specificity and diagnostic confidence,” said Rick Ortega, director of MRI programs at iCAD. "The new advanced MRI product suite will improve workflow efficiencies to aid in expedient clinical decision making and treatment for patients, with an ultimate goal of delivering improved patient care.”

iCAD is a provider of image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable computer-aided detection (CAD) systems and workflow solutions for mammography (film-based, digital radiography and computed radiography), MRI, and computed tomography (CT).

Related Links:
iCAD